Biodexa Pharmaceuticals Plc (BDRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Stephen A. Stamp
Employees:
20
ODDFELLOWS HOUSE, 19 NEWPORT ROAD, CARDIFF, UNITED KINGDOM CF24 0AA
44 (0)1235 888300

Midatech Pharma plc focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme. MTX114, an immuno-suppressant for topical application in psoriasis, MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder.

Data derived from most recent annual or quarterly report
Market Cap 4.576 Million Shares Outstanding34.669 Million Avg 30-day Volume 1.755 Million
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue251.7897 Debt to Equity0.0387 EBITDA-29.804 Million
Price to Book Value12.8556 Operating Margin-6717.194399999999 Enterprise Value107.998 Million
Current Ratio3.103 EPS Growth0 Quick Ratio2.716
1 Yr BETA 1.0496 52-week High/Low 5.2 / 0.12 Profit Margin-6469.0897
Operating Cash Flow Growth-47.7299 Altman Z-Score-7.6806 Free Cash Flow to Firm -1.756 Million
View SEC Filings from BDRX instead.

View recent insider trading info

Biodexa Pharmaceuticals Plc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BDRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BDRX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COCHRANE HAYWOOD D

  • Director
 No longer subject to file 2015-12-04 0

CLEMENT CHRISTOPHER G CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 No longer subject to file 2015-12-04 0

LIEBERMAN GAIL

  • Director
 No longer subject to file 2015-12-04 0

DRUTZ DAVID EXECUTIVE CHAIRMAN AND CMO

  • Officer
  • Director
 No longer subject to file 2015-12-04 0

TOUSLEY DAVID L. CFO

  • Officer
 No longer subject to file 2015-12-04 0

RICHARDSON PAUL JOHN

  • Director
 No longer subject to file 2015-12-04 0

HEADY TIMOTHY JAMES

  • Director
 No longer subject to file 2015-12-04 0

BENHARRIS DAVID SENIOR VICE PRESIDENT

  • Officer
 No longer subject to file 2015-12-04 0

JAEGER STEPHEN O

  • Director
 5,000 2013-05-10 0

GORLIN STEVE

  • Director
 0 2012-05-15 0

ROSAR ANN A VICE PRESIDENT FINANCE

  • Officer
 8,688 2012-05-15 0

THOMAS JOHN C

  • Director
 10,000 2012-02-14 0

FRANCO RICHARD A PRESIDENT & CEO

  • Officer
  • Director
 246,334 2011-05-12 0

KILEY QUINN THOMAS PORTFOLIO MANAGER

  • Officer
 1,000 2011-05-10 0

CAUWENBERGH GEERT

  • Director
 37,917 2009-01-08 0

DIDSBURY JOHN COO AND CHIEF SCIENTIC OFFICER

  • Officer
 9,000 2008-09-09 0

BARBERICH TIMOTHY J

  • Director
 128,938 2006-07-12 0

ROBLE DANIEL T

  • Director
 114,433 2006-07-12 0

WHELAN WILLIAM J JR

  • Director
 114,128 2006-07-12 0

KIEPERT DONALD R JR CHAIRMAN, PRESIDENT, CEO

  • Officer
  • Director
 1,436,196 2006-04-12 0

DUFFY MICHAEL P SVP, GC AND SECRETARY

  • Officer
 396,000 2006-04-12 0

SMALL RICHARD N SENIORVP,CFO,TREASURER

  • Officer
 719,990 2006-04-12 0

UPRICHARD MARGARET J SVP, CHIEF DEVELOPMENT OFFICER

  • Officer
 475,000 2006-04-12 0

JONES BARRY SENIOR VICE PRESIDENT,RESEARCH

  • Officer
 459,070 2006-04-12 0

CLAFLIN THOMAS M II

  • Director
 80,000 2005-12-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 22:15:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 21:45:05 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 21:15:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 20:45:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 20:15:05 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 19:45:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 19:15:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 18:45:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 18:15:03 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 17:45:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 17:15:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 16:45:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 16:15:03 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 15:45:03 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 15:15:03 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 14:45:05 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 14:15:04 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 13:45:05 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 13:15:03 UTC -101.2307 106.3007 200000
BIODEXA PHARMACEUTICALS-ADR BDRX 2023-05-29 12:45:03 UTC -101.2307 106.3007 200000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Armistice Capital LLC Midatech Pharma Plc 1.21% 2020-08-14 UK
Armistice Capital LLC Midatech Pharma Plc 1.16% 2020-08-21 UK

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments